AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Scotride M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Adenscot Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Scotride M 2mg/500mg Tablet SR

Diabexe Duo 2mg/500mg Extended-Release Tablets are classified as anti-diabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, risking complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a rapid-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before starting treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Uses of Scotride M 2mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Scotride M 2mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Scotride M 2mg/500mg Extended-Release Tablet with a meal.

Common Side effects of Scotride M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Scotride M 2mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Scotride M 2mg/500mg sustained-release tablets with food.

How Scotride M 2mg/500mg Tablet SR works:

Scotride M 2mg/500mg Extended-Release Tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Scotride M 2mg/500mg Tablet SR and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Scotride M 2mg/500mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Scotride M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Operating a vehicle could be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Scotride M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Scotride M 2mg/500mg SR tablets. Physician consultation is essential. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Scotride M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; it's contraindicated in patients with severe liver dysfunction.

What if you forget to take Scotride M 2mg/500mg Tablet SR :

Should you forget to take your Scotride M 2mg/500mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed dosage.

Facts to Know About Scotride M 2mg/500mg Tablet SR

LabelValue
Addictive None.
Type of Medication Diabetes medication

FAQs on Scotride M 2mg/500mg Tablet SR

Store this medication in its original, tightly sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Scotride M 2mg/500mg Tablet SR. Also termed Metformin-associated lactic acidosis (MALA), this rare complication poses a significant risk to individuals with pre-existing kidney impairment, the elderly, and heavy alcohol consumers. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should any of these symptoms occur, discontinue Scotride M 2mg/500mg Tablet SR and seek immediate medical attention.
The extended-release tablet Scotride M, containing 2mg glimepiride and 500mg metformin, manages type 2 diabetes mellitus in adults. This dual-action medication enhances glycemic control when coupled with a balanced diet and physical activity. Glimepiride stimulates pancreatic insulin secretion to reduce blood sugar, while metformin decreases hepatic glucose output and improves insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Taking Scotride M 2mg/500mg Extended-Release Tablets may cause common side effects such as low blood sugar, taste changes, nausea, abdominal pain, diarrhea, and headaches. Serious, though infrequent, side effects include lactic acidosis. Prolonged use might result in vitamin B12 deficiency.
Prolonged use of Scotride M 2mg/500mg SR tablets can indeed lead to Vitamin B12 deficiency. This medication impairs the body's ability to absorb Vitamin B12 from the gastrointestinal tract. Consequently, untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, weakness, bladder dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended by some experts on an annual basis.
Indeed, Scotride M 2mg/500mg Extended-Release Tablets may induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Scotride M 2mg/500mg SR tablets and alcohol is unsafe. This combination can depress blood sugar, potentially causing hypoglycemia, and heighten the risk of lactic acidosis.
Scotride M 2mg/500mg Tabl...
92
MRP 112
17% off